MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction)

PHASE3RecruitingINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

May 24, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2028

Conditions
Acute Myocarditis
Interventions
DRUG

Methylprednisolone 125 MG

125 mg daily for 3 days diluted in saline solution 250 mL

OTHER

IV saline solution 0.9%

Saline solution 0.9% 250 mL

Trial Locations (19)

15006

NOT_YET_RECRUITING

Hospital Universitario A Coruña (CHUAC), A Coruña

20125

RECRUITING

Niguarda Hospital, Milan

20132

NOT_YET_RECRUITING

San Raffaele Hospital, Milan

23900

NOT_YET_RECRUITING

Alessandro Manzoni hospital, Lecco

25123

NOT_YET_RECRUITING

ASST Spedali Civili di Brescia, Brescia

Unknown

RECRUITING

Antwerp University Hospital, Edegem

RECRUITING

Onze-Lieve-Vrouwziekenhuis (OLV ziekenhuis), Aalst

RECRUITING

Middelheim Ziekenhuis, Antwerp

RECRUITING

Jessa ziekenhuis, Hasselt

RECRUITING

Universitair ziekenhuis Leuven, Leuven

NOT_YET_RECRUITING

Azienda USL Toscane SUD Est, Arezzo

NOT_YET_RECRUITING

Azienda Ospedaliera Papa Giovanni XXIII, Bergamo

NOT_YET_RECRUITING

Careggi University Hospital, Florence

NOT_YET_RECRUITING

Ospedale Maggiore di Milano, Milan

NOT_YET_RECRUITING

Fondazione IRCCS Policlinico San Matteo, Pavia

NOT_YET_RECRUITING

Fondazione Toscana Gabriele Monasterio, Pisa

NOT_YET_RECRUITING

Policlinico Universitario Agostino Gemelli, Roma

NOT_YET_RECRUITING

Azienda Sanitaria Universitaria Friuli Centrale, Udine

RECRUITING

University Medical Centre of Ljubljana, Ljubljana

All Listed Sponsors
collaborator

Niguarda Hospital

OTHER

lead

University Hospital, Antwerp

OTHER